Tran Capital Management’s Halozyme HALO Stock Holding History

Tran Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,084,118	Closed	-$61.7M	–	40
2022 Q4	$61.7M	Sell	1,084,118 -55,052	-5%	-$2.82M	7.8%	2
2022 Q3	$45M	Sell	1,139,170 -387,123	-25%	-$17.1M	5.76%	7
2022 Q2	$67.2M	Sell	1,526,293 -20,299	-1%	-$878K	7.67%	1
2022 Q1	$61.7M	Buy	1,546,592 +47,016	+3%	+$1.67M	5.41%	5
2021 Q4	$60.3M	Sell	1,499,576 -6,897	-0.5%	-$257K	4.82%	8
2021 Q3	$61.3M	Buy	1,506,473 +155,603	+12%	+$6.51M	5.13%	6
2021 Q2	$61.3M	Sell	1,350,870 -2,338	-0.2%	-$103K	5.06%	4
2021 Q1	$56.4M	Buy	1,353,208 +189,327	+16%	+$8.64M	5.03%	6
2020 Q4	$49.7M	Buy	1,163,881 +79,866	+7%	+$2.87M	4.6%	8
2020 Q3	$28.5M	Buy	1,084,015 +82,568	+8%	+$2.3M	3.07%	18
2020 Q2	$26.8M	Buy	+1,001,447	New	+$22.6M	3.11%	15

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Tran Capital Management's HALO Position: Q1 2023 in Review

Tran Capital Management sold out of Halozyme (HALO) in Q1 2023, closing a stake of 1,084,118 shares — an estimated $61.7M sold.

Tran Capital Management first reported a position in HALO in Q2 2020 and held it in 11 quarters. The position peaked at $67.2M in Q2 2022. 386 funds tracked by Wall St. Rank hold HALO as of Q1 2023.

Tran Capital Management reported no remaining Halozyme position as of Q1 2023 after selling out during the quarter.
Tran Capital Management sold 1,084,118 Halozyme shares in Q1 2023, an estimated $61.7M.
Tran Capital Management first reported a position in Halozyme in Q2 2020 and held it in 11 quarters.
Tran Capital Management's Halozyme position peaked at $67.2M in Q2 2022.
386 funds tracked by Wall St. Rank held Halozyme as of Q1 2023.

Based on Tran Capital Management's 13F filing for Q1 2023, filed 18 Apr 2023.